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Background—The vascular tissue reaction to acute incomplete stent apposition (ISA) is not well known. The aim of this
study was to characterize the vascular response to acute ISA in vivo and to look for predictors of incomplete healing.
Methods and Results—Optical coherence tomography studies of 66 stents of different designs, implanted in 43 patients
enrolled in 3 randomized trials, were analyzed sequentially after implantation and at 6 to 13 months. Seventy-eight
segments with acute ISA were identified in 36 of the patients and matched with the follow-up study by use of fiduciary
landmarks. The morphological pattern of healing in the ISA segments was categorized as homogeneous, layered,
crenellated, bridged, partially bridged, or bare, depending on the persistence of ISA and on the coverage. After 6 months,
acute ISA volume decreased significantly, and 71.5% of the ISA segments were completely integrated into the vessel
wall. Segments with acute ISA had higher risk of delayed coverage than well-apposed segments (relative risk 2.37, 95%
confidence interval 2.01–2.78). Acute ISA size (estimated as ISA volume or maximum ISA distance per strut) was an
independent predictor of ISA persistence and of delayed healing at follow-up.
Conclusions—Neointimal healing tends to reduce ISA, with the malapposed stent struts often integrated completely into
the vessel wall, resulting in characteristic morphological patterns. Coverage of ISA segments is delayed with respect to
well-apposed segments. The larger the acute ISA, the greater the likelihood of persistent malapposition at follow-up and
delayed healing.
Clinical Trial Registration—URL: http://www.clinicaltrials.gov. Unique identifier: NCT00617084 and NCT00934752.
(Circ Cardiovasc Interv. 2012;5:20-29.)
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The vascular tissue reaction to acute incomplete stentapposition (ISA) is not well known. The neointimal
healing process after stenting might spontaneously correct
ISA to some extent, integrating the malapposed regions into
the vessel wall, as suggested by sequential quantitative
studies with optical coherence tomography (OCT), which
reported ISA volumes and percentage of ISA struts decreas-
ing over time.1–4 Other qualitative OCT studies have also
speculated about some morphological patterns at follow-up
and the hypothesis that they could represent the vascular
response to acutely malapposed struts.5 The reasons why the
vascular biology succeeds in covering and even integrating
some ISA regions into the vessel wall but not others remain
poorly understood.
ISA has been linked to delayed neointimal coverage in 2
different scenarios: late-acquired ISA and acute ISA. Intra-
vascular ultrasound studies reported the association between
ISA and late or very late stent thrombosis6,7 in the relatively
rare clinical context of delayed hypersensitivity to drug-
eluting stents, probably triggered by the polymer and recruit-
ing preferentially eosinophils.8,9 Vasculitis of the 3 arterial
layers resulted in weakening of the vessel wall, aneurysmatic
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dilatation, late-acquired ISA, and thrombosis.6,8,9 In this
context, late-acquired ISA struts presented signs of delayed
neointimal coverage.9 On the other hand, the association
between acute ISA and delayed coverage has been demon-
strated only recently.1,10 This association provided some
supporting evidence for the optimization of apposition aimed
at promoting better coverage of the stent. Nevertheless,
regions of minimal acute ISA size appear frequently covered
and even totally integrated in the vessel wall at follow-up.2,3
Thus, the question of what degree of acute ISA is worth
correcting remains unanswered for the interventional
cardiologist.
The aims of the present study were to describe the vascular
tissue reaction to acute ISA in human coronary arteries after 6
months, to characterize quantitatively different morphological
patterns in terms of apposition and coverage, and to look for
predictors at baseline of persisting ISA and delayed coverage.
WHAT IS KNOWN
● Late malapposition has been linked to delayed cov-
erage of stent struts and to stent thrombosis.
● Late malapposition can be the consequence of an
inflammatory process (late-acquired malapposition)
or of acute malapposition (persisting malapposition).
WHAT THE STUDY ADDS
● The neointimal healing process tends to reduce stent
malapposition over time, which results in complete
integration of the malapposed struts into the vessel
wall in 71.5% of the cases.
● Coverage of acutely malapposed segments is delayed
with respect to well-apposed segments in a sequen-
tial and matched cohort (relative risk 2.37, 95%
confidence interval 2.01–2.78).
● The larger the acute malapposition, the greater the
likelihood of persistent malapposed segments at
follow-up and delayed healing.
Methods
Study Sample
OCT images from 3 different randomized trials were analyzed:
the RESOLUTE-All Comers trial (Randomized, Two-Arm, Non-
inferiority Study Comparing Endeavor-Resolute Stent With Ab-
bott Xience-V Stent; NCT00617084),11,12 the De Novo Pilot
Study (NCT00934752),3 and the SECRITT trial (Shield Evaluated
at Cardiac Hospital in Rotterdam for Investigation and Treatment
of TCFA).13
The RESOLUTE-All Comers trial compared a zotarolimus-
eluting stent with a hydrophilic-polymer coating (Resolute;
Medtronic Cardio Vascular, Santa Rosa, CA) versus an everolimus-
eluting stent with fluoropolymer (Xience V; Abbott Vascular, Santa
Clara, CA) in a nonselected all-comers population.11 Twenty percent
of the enrolled patients were randomly allocated to angiographic
follow-up at 13 months. The patients undergoing angiographic
follow-up in selected OCT centers were included in an OCT
substudy, with the proportion of covered struts at 13 months as the
primary end point.12 A sequential OCT study was not mandatory per
protocol.
The De Novo Pilot Study assessed the performance of a paclitaxel-
coated balloon (Moxy; Lutonix Inc, Maple Grove, MN) in combi-
nation with a bare-metal stent (Multi-link Vision/MiniVision; Abbott
Vascular, Santa Clara, CA) for the treatment of de novo coronary
lesions. Myocardial infarction was an exclusion criterion for this
study, and a single lesion per patient could be included. The trial
randomized the sequence of application (balloon first versus stent
first), with a primary end point of percent neointimal volume
obstruction assessed by OCT at 6 months.3
The SECRITT trial studied the efficacy of a nitinol self-
expandable bare-metal stent with ultrathin struts (56 m) and low
chronic outward force (vProtect Luminal Shield; Prescient Medical
Inc, Doylestown, PA) for the treatment of high-risk thin-cap fibro-
atheromas.13 Patients undergoing catheterization for stable or unsta-
ble angina were included if the culprit lesion met the following
criteria: (1) Intermediate 40% to 50% diameter stenosis on quanti-
tative coronary angiography; (2) fractional flow reserve 0.75; and
(3) morphology of thin-cap fibroatheromas in the combination of
intravascular ultrasound radiofrequency and OCT studies, as de-
scribed previously.14,15 Patients were randomized to receive a self-
expandable bare-metal stent or medical therapy. OCT follow-up was
scheduled after 6 months.
In the 3 trials, the optimization of PCI results was guided by
angiography; therefore, no additional intervention was performed
after stent implantation and OCT acquisition, irrespective of the
findings in the OCT images.
OCT Study and Analysis
OCT pullbacks were obtained with M2, M3, or C7 systems (Lightlab
Imaging; Westford, MA), according to availability at the participat-
ing sites, by use of occlusive or nonocclusive techniques as appro-
priate.16 Online-only Data Supplement Table 1 summarizes the
patients studied with each system and the corresponding technical
specifications. Infusion of intracoronary nitroglycerin before OCT
pullback was strongly encouraged.
OCT pullbacks were analyzed offline in a core laboratory (Car-
dialysis BV, Rotterdam, The Netherlands) by independent staff
blinded to stent-type allocation and clinical and procedural charac-
teristics of the patients, using proprietary software (Lightlab Imag-
ing). Cross sections were analyzed at 1-mm longitudinal intervals
within the stented segment. A metallic strut typically appears as a
bright signal-intense structure with dorsal shadowing. Apposition
was assessed strut by strut by measuring the distance between the
strut marker and the lumen contour. The marker of each strut was
placed at the adluminal leading edge, in the midpoint of its long axis,
and the distance was measured following a straight line that
connected this marker with the center of gravity of the vessel.17
Struts were classified as ISA if the distance between the strut marker
and the lumen contour was greater than the specific strut (plus
polymer) thickness.12,18 This resulted in ISA thresholds of 89 m
for everolimus-eluting stents, 97 m for zotarolimus-eluting
stents, 81 m for a drug-coated balloon in combination with a
bare-metal stent, and 56 m for self-expandable bare-metal stents.
Struts located at the ostium of side branches, with no vessel wall
behind them, were labeled as nonapposed side-branch struts and
excluded from the analysis of apposition.3,4,10,12 Struts were classi-
fied as uncovered if any part of the strut was visibly exposed to the
lumen or as covered if a layer of tissue was visible over all the
reflecting surfaces.3,4,10,12,19–24
ISA Segments, Matching, and Morphological
Patterns at Follow-Up
ISA segments were defined as 2 consecutive cross sections that
contained ISA struts immediately after implantation (baseline). ISA
segments extended proximally and distally to fiduciary landmarks in
the vicinity of the most proximal and distal ISA cross sections. These
fiduciary landmarks enabled the matching of the ISA segments with
the follow-up studies. The vascular reaction to acute malapposition
was categorized according to the morphological pattern at follow-up
as follows: (1) Homogeneous (ISA integrated into the vessel wall,
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Figure 1. A–C, Vascular reaction to acute malapposition, categorized according to morphological pattern at follow-up: Homogeneous
(A), layered (B), or crenellated (C). In these patterns, the regions of acute malapposition have been integrated into the arterial wall. D–F,
Vascular reaction to acute malapposition, categorized according to the morphological pattern at follow-up: Bridged (D), partially
bridged (E), or bare (F). In these patterns, the regions of acute malapposition remain malapposed at follow-up.
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Figure 1 (Continued).
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covered with a homogeneous density, and retaining a smooth lumen
contour; Figure 1A); (2) layered (ISA integrated into the vessel wall,
covered with a double or triple density, often with a layered
appearance, and retaining a smooth lumen contour; Figure 1B); (3)
crenellated (ISA integrated into the vessel wall and grossly covered
but presenting indentations that gave the lumen contour a scalloped
appearance; Figure 1C); (4) bridged (persisting ISA, entirely covered
by a rim of tissue linking the vessel intima with the malapposed
struts; Figure 1D); (5) partially bridged (persisting ISA; a rim of
tissue linking the vessel intima with the malapposed struts could be
seen but did not cover all the ISA struts; Figure 1E); or (6) bare (ISA
uncovered struts, with scarce tissue reaction, showing a morpholog-
ical pattern very similar to that observed at baseline; Figure 1F).
Delayed healing was defined by patterns 3 through 6; persistent ISA
was defined by patterns 4 through 6; grossly delayed healing was
defined by patterns 5 and 6. Two independent operators qualitatively
classified the ISA segments at follow-up as the worst morphological
pattern present in the segment. In case of disagreement, the final
category was obtained on consensus after joint review.
Statistical Analysis
Interobserver agreement regarding the classification of the patterns
was measured with a quadratic weighted -statistic. Continuous
variables in the volumetric analysis were compared with multilevel
linear regression for paired measurements (baseline versus follow-
up) using linear mixed models with the time sequence as the fixed
effect and the hierarchical modeling of the measurements as the
random effect. Differences in apposition and coverage between the
different morphological patterns were analyzed with a Kruskal-
Wallis test, and a linear trend among the ranked categories was
explored with the Jonckheere-Terpstra test. The relative risk for
delayed coverage of ISA versus well-apposed segments was calcu-
lated by pooled analysis with an inverse-variance random effects
model, taking into account the between-clusters and within-cluster
variability and considering each stent as an independent unit of
clustering.10 Predictors of persistent ISA, grossly delayed coverage,
percent of ISA, and percent of uncovered struts were studied by
multilevel regression using generalized estimating equations to
correct for clustering of data. The goodness of fit of the model that
contained the significant predictors of the effect was estimated by the
corrected quasi-likelihood under the independence model criterion
(QICC); the lower the QICC values, the better the fit of the model.
Calculations were performed with PASW 17.0 (Chicago, IL) and
CMA version 2 (Biostat Inc, Englewood, NJ) software packages.
Results
Forty-eight lesions and 66 stents implanted in 43 patients
were ultimately available for sequential analysis among the
population included in the present study (Figure 2). Tables 1
and 2 summarize the baseline clinical and procedural char-
acteristics of the patients and angiographic characteristics of
the lesions, respectively. Seventy-eight segments with acute
ISA were identified in 36 patients at baseline. Matching with
the OCT at follow-up was not possible in 8 segments because
of lack of fiduciary landmarks (3 cases), out-of-image artifact
(3 cases), or incomplete follow-up pullbacks that did not
include the ISA segment (2 cases). The following results
correspond to the 70 matched segments (32 patients).
Analysis of Morphological Patterns at Follow-Up
The distribution of the morphological patterns at follow-up
in the ISA segments is provided in online-only Data Supple-
ment Table 2. The agreement between the initial classifica-
tions of the 2 observers was very high (weighted  0.96, 95%
confidence interval 0.94–0.98). The most frequent pattern
was the homogeneous pattern (32.9%), with decreasing pro-
portions in the subsequent ordered patterns, up to the bare
pattern (2.9%). Of the analyzed segments, 71.5% had a
pattern of spontaneous reapposition onto the vessel wall. The
proportion of uncovered, ISA, and ISA-uncovered struts in
the quantitative analysis varied significantly between the
patterns (P0.0001), following a significant linear trend in
the ranked categories (P0.0001; Table 3; Figure 3). The
most significant step-up for delayed coverage was observed
between the layered and crenellated categories (median per-
centage of uncovered struts 0.0% and 10.0%, respectively),
whereas the most significant step-up for ISA was observed
Figure 2. Flow chart summarizing the
patients and stents included in the pres-
ent study, pooled from 3 different ran-
domized trials with optical coherence
tomography (OCT). BL indicates baseline
study after stent implantation; DCB-BMS,
drug-coated balloon in combination with
bare-metal stent; EES, everolimus-eluting
stent; SE-BMS, self-expandable bare-
metal stent; and ZES, zotarolimus-eluting
stent.
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between crenellated and bridged (median percentage of ISA
struts 0.0% and 13.7%, respectively).
Quantitative Analysis of ISA Segments
Three segments were excluded from the quantitative anal-
ysis because ISA was located at one of the stent edges,
with very different vessel-catheter coaxiality between
baseline and follow-up studies, thus making the sequential
volumetric calculations unreliable. Table 4 shows the
volumetric analysis of the ISA segments. A significant
reduction in lumen and ISA areas was observed (online-
only Data Supplement Figure 1).
Raw per-strut analysis of apposition and coverage is
provided in online-only Data Supplement Table 3. The raw
proportion of ISA struts in ISA segments was reduced from
37.7% at baseline to 11.8% at follow-up. The incidence of
delayed coverage in the ISA segments was 15.4% versus
5.9% in the corresponding well-apposed segments of the
same stents (pooled relative risk 2.37; 95% confidence
interval 2.01–2.78; online-only Data Supplement Table 4 and
online-only Data Supplement Figure 2).
Predictors of Persistence of ISA and of
Delayed Coverage
Type of stent and 1 estimator of the ISA size at baseline
(either ISA volume or maximum distance to the vessel wall
per strut) were tested as predictors of the vascular healing
Table 1. Patient and Procedural Baseline Characteristics
Patients (n43)
Age, y 60.4 (10.8)
Males, n (%) 35 (81.4)
Cardiovascular risk factors, n (%)
Hypertension 23 (53.5)
Diabetes mellitus 8 (18.6)
Insulin-requiring 1 (2.3)
Hypercholesterolemia 33 (76.7)
Smoking 20 (46.5)
Current smoker (30 d) 10 (23.3)
Family history of CHD 17 (39.5)
Antecedents, n (%)
Previous MI 15 (34.9)
Previous PCI 9 (20.9)
Previous CABG 2 (4.7)
Clinical presentation, n (%)
TCFA 8 (18.6)
Silent ischemia 1 (2.3)
Stable angina 19 (44.2)
Unstable angina 12 (27.9)
Myocardial infarction 3 (7.0)
STEMI 2 (4.7)
Procedural characteristics
No. of vessels treated 1.43 (0.63)
No. of lesions treated 1.62 (0.79)
No. of stents implanted 1.67 (1.27)
Total stented length, mm 30.4 (29.9)
Small vessel (2.5 mm diameter), n (%) 20 (46.5)
Overlap, n (%) 7 (16.3)
Type of stent, n (%)
EES 8 (18.6)
ZES 6 (14.0)
DCB-BMS 21 (48.8)
SE-BMS 8 (18.6)
CHD indicates coronary heart disease; MI, myocardial infarction; PCI,
percutaneous coronary intervention; CABG, coronary artery bypass graft; TCFA,
thin cap fibroatheroma; STEMI, ST-elevation myocardial infarction; EES,
everolimus-eluting stent; ZES, zotarolimus-eluting stent; DCB-BMS, combina-
tion of drug-coated balloon with bare-metal stent; SE-BMS, self-expandable
bare-metal stent.
Table 2. Angiographic Characteristics of the Lesions
Lesions (n48)
Target vessel, n (%)
LAD 19 (39.6)
LCx 5 (10.4)
RCA 23 (47.9)
Total occlusion, n (%) 3 (6.3)
Ostial lesion, n (%) 1 (2.1)
Bifurcation, n (%) 12 (25.0)
Moderate or severe calcification, n (%) 9 (18.8)
QCA characteristics, mean (SD)
Lesion length, mm 12.7 (7.7)
Before stenting
RVD, mm 2.62 (0.46)
MLD, mm 1.04 (0.60)
Percent diameter stenosis 61.03 (20.35)
Poststenting in-stent
RVD, mm 2.74 (0.39)
MLD, mm 2.29 (0.42)
Percent diameter stenosis 13.97 (8.11)
LAD indicates left anterior descending coronary artery; LCx, left circumflex
coronary artery; RCA, right coronary artery; QCA, quantitative coronary
angiography; RVD, reference vessel diameter; MLD, minimal lumen diameter.
Table 3. Percentage of Uncovered, ISA, and ISA-Uncovered
Struts in Segments With Acute Malapposition, According to
Morphological Pattern at Follow-Up
% of Struts
Pattern Uncovered ISA ISA-Uncovered
Homogeneous 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
Layered 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
Crenellated 10.0 (0.0–24.0) 0.0 (0.0–7.8) 0.0 (0.0–4.2)
Bridged 8.2 (6.0–23.5) 13.7 (0.0–18.8) 1.3 (0.0–8.3)
Partially
bridged
21.0 (9.8–32.0) 17.4 (13.5–24.1) 10.3 (5.5–15.9)
Bare 17.1 (12.5–21.7) 10.7 (8.3–13.0) 7.5 (6.3–8.7)
Values are median (25th percentile–75th percentile); n70 segments, 32
patients.
ISA indicates incomplete stent apposition.
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reaction at follow-up. ISA size was the only independent
predictor of a pattern of persistent ISA or grossly delayed
coverage at follow-up, with similar predictive value when
ISA size was estimated by ISA volume as when it was
estimated by the maximum ISA distance per strut (online-
only Data Supplement Figure 3). ISA size and the type of
stent were both independent predictors of a pattern of delayed
coverage, with similar predictive values for the models with
ISA volume or with maximum ISA distance per strut as
estimators of ISA size. The percentage of ISA struts in the
segment at follow-up could be predicted by the ISA volume
after implantation (P0.0001; QICC 336.87) or by the
maximum ISA distance per strut (P0.0001; QICC 342.64)
alone, whereas the percentage of uncovered struts at
follow-up was predicted by ISA size after implantation
(P0.02 for ISA volume, P0.04 for maximum ISA distance
per strut) and by the type of stent (P0.045; QICC 5056.30
for the model with ISA volume and QICC 5389.10 for the
model with maximum ISA distance per strut).
Table 5 shows an estimation of the likelihood at follow-up
of resolved versus persistent ISA and of grossly covered
versus grossly delayed patterns of healing, based on the
analysis of the present sample. Maximum ISA distances
270 m after stent implantation appeared grossly cov-
ered and spontaneously reapposed in 100% of cases at
follow-up, whereas maximum ISA distances 850 m
resulted in persisting ISA and grossly delayed coverage in
100% of cases.
Clinical Outcomes
At the time of OCT follow-up, 6 patients had experienced
major adverse cardiovascular events, all of them in the group
with a drug-coated balloon in combination with a bare-metal
stent: 1 periprocedural non–Q-wave MI, 1 target-vessel–
related non–Q-wave MI at follow-up, and 4 clinically driven
target-vessel revascularizations (because of stable angina).
No case of stent thrombosis occurred in any of the subgroups.
Discussion
The main findings of the present study are as follows: (1) The
vascular tissue reaction to acute ISA can be described by
OCT according to simple morphological patterns that repre-
sent different degrees of persisting malapposition and cover-
age. (2) The neointimal response tends to reduce ISA size,
often resulting in the malapposed struts being completely
integrated into the vessel wall. (3) Within the same stent,
coverage of ISA segments is delayed with respect to that of
well-apposed segments. (4) The size of acute ISA is directly
associated with its persistence at follow-up and with delayed
coverage.
To the best of our knowledge, this is the first sequential
OCT study describing the healing process of acute ISA both
Figure 3. Graphic showing the median percentage
of uncovered, ISA, and ISA-uncovered struts in the
segments with acute malapposition according to
the morphological pattern at follow-up. ISA indi-
cates incomplete stent apposition.
Table 4. Areas and Volumetric Analysis of ISA Segments, Baseline Versus Follow-Up Results
95% CI
PBaseline Follow-Up Mean Difference Lower Upper
Length, mm 2.0 (0.3) 1.9 (0.3) 0.1 (0.5) 1.1 0.8 0.780
MLA, mm2 8.05 (0.32) 6.71 (0.32) 1.34 (0.45) 2.23 0.45 0.003
Mean lumen area, mm2 8.47 (0.33) 7.14 (0.33) 1.33 (0.47) 2.25 0.42 0.005
Mean stent area, mm2 8.09 (0.31) 7.99 (0.31) 0.10 (0.44) 0.97 0.77 0.819
Maximum ISA area, mm2 0.79 (0.11) 0.29 (0.11) 0.50 (0.16) 0.82 0.19 0.002
Mean ISA area, mm2 0.60 (0.08) 0.19 (0.08) 0.41 (0.11) 0.62 0.20 0.0001
ISA volume, mm3 1.44 (0.40) 0.68 (0.40) 0.76 (0.57) 1.89 0.37 0.184
Values are mean (SE). n67 segments 30 patients.
ISA indicates incomplete stent apposition; CI, confidence interval; MLA, minimal lumen area.
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qualitatively and quantitatively and the first to link simple
morphological qualitative patterns of healing with specific
malapposition and coverage rates in the subsequent quantita-
tive analysis. This observation might enable semiquantitative
estimations of coverage and apposition, which could be
potentially useful for in situ clinical decision making.
The vascular tissue reaction ends in the complete integra-
tion of the ISA into the vessel wall in most cases (71.5%), but
2 of 3 cases of acute ISA have a morphological healing
pattern other than homogeneous. This might represent the in
vivo correlate of some experimental observations: (1) Reen-
dothelialization that ensues after a vessel injury occurs by
proliferation of endothelial and smooth muscle cells, starting
from the uninjured margins until the endothelial continuity is
restored.25–29 At this point, the confluence of endothelial cells
inhibits their own proliferation and stimulates the secretion of
heparin sulfates, which in turn inhibit the proliferation of
smooth muscle cells.30 According to this confluent model,
endothelial cells would spread out on the surface of the
malapposed struts, resulting in conformal coverage of
the detached mesh. The bridged pattern might represent the
maturation of this neointimal conformal coverage. (2) This
reendothelialization process is limited in time26–28: It stops
after 2 weeks (in the rabbit) or after 6 weeks (in the rat),
regardless of whether endothelial continuity has been re-
stored.25,29 The partially bridged and bare patterns (grouped
as “grossly delayed coverage”) might represent the failure of
neointima to cover large ISA regions before the vascular
healing response ceases. This is consistent with our finding of
large acute ISA volumes associated with patterns of grossly
delayed coverage at follow-up. Likewise, small ISA volumes
could induce a conformal bridged pattern of healing that ends
up connecting the ISA struts with the vessel wall (homoge-
neous pattern) or that creates a false lumen that undergoes
subsequent low-flow and thrombosis phenomena (layered
pattern). The layered pattern might also be caused by the
cytotoxicity of specific drugs or stents31 or by the increased
presence of fibrinoid or proteoglycans.32,33 Finally, the cren-
ellated pattern has been proposed to be the result of a vascular
reaction to acute ISA.5 The present findings confirm the
hypothesis that the crenellated pattern appears as 1 of the
possible vascular reactions to acute ISA and is associated
with delayed coverage. The abnormally hyporeactive neoin-
tima that leads to a bare pattern might reflect something other
than the mere failure to restore a too large ISA region and
deserves further investigation.
The quantitative results constitute additional and definitive
evidence about the higher risk of delayed coverage associated
with acute ISA, as suggested and demonstrated by previous
OCT studies.1,10 This is a truly sequential study with the
finest level of matching possible (segments), thus comple-
menting the limitations of previous analytic studies.10 Al-
though the evidence provided by this approach is only at an
ecological level (ie, the uncovered struts could theoretically
be the well-apposed struts in the segment), the consistency
with previous studies that used different approaches1,10
should constitute definitive evidence of the association be-
tween acute ISA and delayed coverage.
The larger the ISA, the more likely it is to persist at
follow-up and to present a pattern of grossly delayed cover-
age. The size of acute ISA can be estimated by different
parameters. Estimation by ISA volume is very accurate but
cannot be accomplished in a straightforward manner; hence,
this parameter is of limited utility for decision making in the
catheterization laboratory. Conversely, maximum ISA dis-
tance per strut can be measured directly in situ and has a
predictive value equivalent to that of ISA volume for the
persistence of ISA and for coverage; therefore, it might be
preferable as an objective criterion for optimization of acute
ISA in the catheterization laboratory. Although the present
study can provide some rationale for the optimization of
apposition, the clinical benefit of such an approach remains
unproven. Interestingly, the coverage rate cannot be predicted
by ISA size alone (except in cases of grossly delayed
coverage) but also depends on the type of stent.
Study Limitations
OCT coverage correlates with histological neointimal healing
and endothelialization after stenting in animal models,21,34 but
its sensitivity and specificity in human atherosclerotic vessels
Table 5. Predictive Values for Resolved vs Persistent ISA and
for Grossly Covered Versus Grossly Delayed Healing Patterns at
Follow-Up of Different Thresholds of ISA Size at Baseline
Percentage Likelihood at Follow-Up
ISA Size
at Baseline
Resolved
ISA
Grossly
Covered
Persistent
ISA
Grossly
Delayed
Healing
ISA volume,
mm3
0.1 100 100 . . . . . .
0.2 96.9 100 . . . . . .
2.5 84.5 93.4 . . . . . .
4.4 79.0 93.1 . . . . . .
12.5 74.2 89.4 . . . . . .
0.1 . . . . . . 34.6 18.6
0.2 . . . . . . 47.2 22.9
2.5 . . . . . . 100 44.4
4.4 . . . . . . 100 66.7
12.5 . . . . . . 100 100
Maximum ISA
distance, m
270 100 100 . . . . . .
350 94.9 100 . . . . . .
400 92.7 97.6 . . . . . .
520 83.3 92.6 . . . . . .
850 75.4 87.9 . . . . . .
270 . . . . . . 46.15 20.5
350 . . . . . . 57.1 26.9
400 . . . . . . 57.7 28.6
520 . . . . . . 69.2 30.8
850 . . . . . . 100 100
n67 Segments, 30 patients.
ISA indicates incomplete stent apposition.
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are unknown. For the 14 patients in the RESOLUTE-All
Comers trial, the follow-up period was 13 instead of 6 months
because of the sustained kinetics of release of the device and
to ensure that OCT studies were performed after the neoin-
timal healing process had achieved its maximum potential.
The heterogeneity of devices and follow-up periods compels
us to classify our results as preliminary and to replicate this
analysis in more specific scenarios and larger samples.
Primary stenting in ST-elevation myocardial infarction
predisposes to acute ISA.35 The present sample included only
2 cases with ST-elevation myocardial infarction. Thus, the
role of the clinical indication on the healing of ISA requires
clarification in larger samples that include more patients with
ST-elevation myocardial infarction.23,24,35
Conclusions
The neointimal healing process tends to reduce ISA size,
often integrating it completely into the vessel wall, and results
in characteristic morphological patterns. The coverage of ISA
segments is delayed with respect to well-apposed segments.
The larger the acute ISA, the greater the likelihood of both
persistent malapposition at follow-up and delayed healing.
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 1 
SUPPLEMENTAL MATERIAL. 
 
 
Supplemental tables. 
 
 
Supplemental table 1: Technical specifications of the different OCT systems and 
number of patients studied with each model at baseline and follow-up. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All systems and catheters from Lightlab Imaging, Westford, Massachusetts, USA. 
 M2 M3 C7 
Technique Occlusive Non-occlusive Non-occlusive 
Domain Time Time Fourier 
Catheter ImageWire ImageWire Dragonfly 
Rotation speed (frames/s) 15.6 20 100 
Pullback speed (mm/s) 2 3 10-20 
EES 1 7 0 
ZES 0 6 0 
DCB-BMS 0 0 21 
Post-stent 
implantation 
SE-BMS 0 6 2 
Total nr of patients 1 19 22 
EES 0 7 1 
ZES 0 6 0 
DCB-BMS 0 0 21 
Follow-up 
SE-BMS 0 3 5 
Total nr of patients 0 16 27 
 2 
Supplemental table 2: Morphologic patterns at follow-up in the regions with acute 
malapposition at baseline, stratified by type of stent. 
 
 
DCB-BMS: Combination of drug-coated balloon with bare metal stent; EES: 
Everolimus-eluting stent; SE-BMS: Self-expandable bare metal stent; ZES: 
Zotarolimus-eluting stent. 
 Homogeneous Layered Crenellated Bridged Partially bridged Bare 
EES           (n=14) 9 (64.3%) 0 (0.0%) 0 (0.0%) 4 (28.6%) 0 (0.0%) 1 (7.1%) 
ZES            (n=13) 5 (38.5%) 0 (0.0%) 4 (30.8%) 2 (15.4%) 2 (15.4%) 0 (0.0%) 
DCB-BMS  (n=31) 9 (29.0%) 11(35.5%) 5 (16.1%) 4 (12.9%) 1 (3.2%) 1 (3.2%) 
SE-BMS     (n=12) 0 (0.0%) 3 (25.0%) 4 (33.3%) 1 (8.3%) 4 (33.3%) 0 (0.0%) 
Total          (n=70) 23 (32.9%) 14 (20.0%) 13 (18.6%) 11 (15.7%) 7 (10.0%) 2 (2.9%) 
 3 
Supplemental table 3: Analysis per strut of apposition and coverage in the matched 
stents. 
 
 
Values are count (%) of struts. 
BL: Baseline; DCB-BMS: Drug-coated balloon in combination with bare metal stent; 
EES: Everolimus-eluting stent; FU: Follow-up; ISA: Incomplete stent apposition; 
NASB: Non-apposed side-branch strut; SE-BMS: Self-expandable bare metal stent; 
ZES: Zotarolimus-eluting stent. 
Malapposed stents 
ISA segments Well-apposed segments 
Well-apposed stents n=66 stents 
43 patients 
BL FU BL FU BL FU 
Well-apposed 1345 (62.2%) 2164 (87.9%) 5002 (94.4%) 4870 (98.8%) 5347 (99.3%) 5563 (99.7%) 
ISA 815 (37.7%) 290 (11.8%) 237 (4.5%) 19 (0.4%) 6 (0.1%) 3 (0.1%) Apposition 
NASB 3 (0.1%) 7 (0.3%) 55 (1.0%) 39 (0.8%) 30 (0.6%) 11 (0.2%) 
Uncovered 2163 (100%) 379 (15.4%) 5924 (100%) 289 (5.9%) 5383 (100%) 251 (5.3%) 
           ISA-uncovered 815 (37.7 %) 146 (5.9%) 237 (4.5%) 16 (0.3%) 6 (0.1%) 3 (0.1%) 
TOTAL 2163 2461 5294 4928 5383 5577 
 4 
Supplemental table 4: Relative risk for delayed coverage in ISA vs. non-ISA segments 
pooled by stent, and stratified by the type of stent. 
 
Magnitude of effect Heterogeneity of the effect 
95% CI 
 
n 
RR 
Lower Upper 
p val I2 τ2
 
All 52 2.34 2.01 2.78 <0.0001 50.20 0.38 
     EES 9 4.10 2.52 6.65 0.005 63.92 1.21 
     ZES 11 2.57 1.98 3.34 0.110 36.15 0.12 
     DCB+BMS 26 2.01 1.56 2.60 0.010 43.62 0.44 
     SE-BMS 6 1.68 0.96 2.95 0.036 58.06 0.86 
 
DCB-BMS: Drug-coated balloon in combination with bare metal stent; EES: 
Everolimus-eluting stent; RR: Relative risk; SE-BMS: Self-expandable bare metal stent; 
ZES: Zotarolimus-eluting stent. 
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Supplemental figures. 
 
 
Supplemental figure 1.  
 
 
 
 6 
Supplemental figure 2. 
 7 
Supplemental figure 3. 
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 Figures legends. 
 
Supplemental figure 1: ISA volume immediately after stent implantation (T0) and 
at follow-up (T1), stratified by type of stent (left panel) and by clinical indication 
(right panel).  
 
 
AMI: Acute myocardial infarction; DCB-BMS: Drug-coated balloon in combination 
with BMS; EES: Everolimus-eluting stent; ISA: Incomplete stent apposition struts; SE-
BMS: Self-expandable bare-metal stent; TCFA: Thin cap fibroatheroma; UA: Unstable 
angina; ZES: Zotarolimus-eluting stent. 
 
 
Supplemental figure 2: Forest plot showing the pooled relative risk of delayed 
coverage at 6-13 months in malapposed vs. well-apposed segments, stratified by 
type of stent. 
Lines represent the 95% confidence interval for the relative risk in each stent, with the 
pooled relative risk at the bottom. 
 
 
DCB-BMS: Drug-coated balloon in combination with bare metal stent; EES: 
Everolimus-eluting stent; ISA: Incomplete stent apposition struts; SE-BMS: Self-
expandable bare metal stent; ZES: Zotarolimus-eluting stent. 
 
 
Supplemental figure 3: Predictors of complete vs. delayed healing, resolved vs. 
persistent ISA and grossly covered vs. grossly delayed healing patterns. Stent type 
and ISA size at baseline were both predictors of delayed healing, with similar predictive 
value of the model using either ISA volume (white cells) or maximal ISA distance per 
strut (yellow cells). ISA size at baseline was the only independent predictor of persistent 
ISA or grossly delayed coverage. 
 
QICC: Corrected quasi-likelihood under independence model criterion. 
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